Oric Pharmaceuticals, Inc. (ORIC)
10.42
-0.01
(-0.10%)
USD |
NASDAQ |
Apr 24, 13:26
Oric Pharmaceuticals EPS Diluted (Quarterly) : -0.2974 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Amgen, Inc. | 2.455 |
| Olema Pharmaceuticals, Inc. | -0.5044 |
| Tango Therapeutics, Inc. | -0.2945 |
| Tyra Biosciences, Inc. | -0.5655 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.50M |
| Total Expenses (Quarterly) | 30.50M |
| Enterprise Value | 894.19M |
| Earnings Yield | -14.54% |
| Normalized Earnings Yield | -14.54 |